Why Pfizer's 2017 Was Mediocre at Best Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pfizer’s 2017 wasn’t horrible. Just ho-hum. Source: BioSpace You Might Also Like 3 Biotechs Facing Stiff Headwinds in 2018 February 13, 2018 4 Large Cap Pharmas That Could Post Huge Earnings October 19, 2017 <b>eSight</b> 3 Launches In Europe June 22, 2017
